🟢 Tiziana Life Sciences is trading 10.18% up with no confirmed company-specific announcement

Tiziana Life Sciences is trading 10.18% up at $1.25 on October 9, 2026, with no confirmed company-specific announcement identified for the move.

• The company’s latest listed press release was its September 30 FDA orphan-drug designation filing.
• The supplied sector context reports the XBI up 2.50%, alongside positive IPO and deal activity. This may be supportive but does not establish a direct cause of Tiziana Life Sciences’ larger move.
• No trading-volume information was provided.